Integra LifeSciences names Stuart Essig president and CEO in leadership transition

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

IART

0.00

  • Integra LifeSciences named Stuart Essig president and CEO, returning to the role on a non-interim basis.
  • Essig has served as board chairman since June 2012, was a director since 1997, previously led Integra as CEO from 1997 to early 2012, served as president from 1997 to 2010.
  • Michael McBreen appointed chief commercial officer in a newly created role, overseeing both divisions and global commercial structure.
  • McBreen brings more than 30 years of commercial experience in medical technology.
  • Leadership changes positioned to sharpen execution, elevate customer and commercial focus, support performance priorities through 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.